NCT00723502 - Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Gram-Negative Bacterial InfectionsHelicobacter InfectionsDyspepsia

Interventions

DRUG

Finafloxacin + Amoxicillin

Finafloxacin, tablets, 400 mg b.i.d. (8 X 50 mg tablets), oral administration; Amoxicillin, tablet 1000 mg b.i.d. (1 X 1000 mg tablet), oral administration

DRUG

Finafloxacin + Esomeprazole

Finafloxacin, tablets, 400 mg b.i.d. (8 X 50 mg tablets), oral administration; Esomeprazole, tablet, 40 mg b.i.d. (1 X 40 mg tablet), oral administration

Trial Locations (1)

35037

Dr. Hein, Marburg